A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2002
12/18/2002	EP1265630A2 Use of insulin for the treatment of cartilagenous disorders
12/18/2002	EP1265629A1 Use of growth hormone in low dose
12/18/2002	EP1265628A1 Use of human not1 and not1a orphan receptors
12/18/2002	EP1265627A2 Methods and compositions for inhibiting angiogenesis
12/18/2002	EP1265626A1 Method for reducing allergen-induced airway hyperresponsiveness
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1265605A1 $g(b)-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS
12/18/2002	EP1265602A2 Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries
12/18/2002	EP1265596A2 Medical emulsion for lubrication and delivery of drugs
12/18/2002	EP1265570A1 Soluble keratin peptide
12/18/2002	EP1098898B1 Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino] -1-benzyl-2- (phosphonooxy) propylcarbamate
12/18/2002	EP1068240B1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
12/18/2002	EP0973801B1 GnRH ANTAGONISTS
12/18/2002	EP0948349B1 in vitro methods and use of pharmaceutical compositions for the TREATMENT OF INNER EAR HAIR CELLS
12/18/2002	EP0946721B1 Human growth gene and short stature gene region
12/18/2002	EP0946502B1 Sulfonamide interleukin-beta converting enzyme inhibitors
12/18/2002	EP0938331B1 Therapeutic uses of bpi protein products in cystic fibrosis patients
12/18/2002	EP0892811B1 Peptides with antiproliferative properties
12/18/2002	EP0876478A4 Monoclonal antibody to herpes simplex virus and cell line producing same
12/18/2002	EP0871473B1 Use of il-10 for wound healing with reduced scarring
12/18/2002	EP0859784B1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
12/18/2002	EP0811068B1 HUMAN DNase I VARIANTS
12/18/2002	EP0789583B1 Methods and kits using macrophage stimulating protein
12/18/2002	EP0784485B1 VACCINE COMPOSITIONS containing partially deacetylated chitin
12/18/2002	EP0769018B1 Helicobacter proteins and vaccines
12/18/2002	EP0736002B9 Compound capable of introducing at least one molecule into a cell
12/18/2002	EP0726944B1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
12/18/2002	EP0715523B1 Purine nucleoside phosphorylase gene therapy for human malignancy
12/18/2002	EP0662150B1 Maspin, a novel serpin with tumor suppressing activity
12/18/2002	EP0641385B1 Development of dna probes and immunological reagents of human tumor associated antigens
12/18/2002	EP0630255B1 Mhc conjugates useful in ameliorating autoimmunity
12/18/2002	CN1385532A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1385531A Dilutus culex chymotrypsin gene
12/18/2002	CN1385529A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1385441A Novel human lymphokine, its coding sequence and use
12/17/2002	US6495735 Transgenic non-human mammals expressing DNA sequences encoding homologous complement restriction factors of a discordant mammalian species
12/17/2002	US6495699 Antiarthritic agents; osteoporosis
12/17/2002	US6495675 Pharmaceutical composition for treating or preventing influenza, and novel capped oligonucleotide
12/17/2002	US6495668 Isolated protein comprising a first polypeptide disulfide-bonded to a second polypeptide, wherein each of said first and second polypeptides is from 113 to 138 amino acid residues in length and comprises amino acid residues 258-370
12/17/2002	US6495667 Il-b30 antibodies
12/17/2002	US6495666 Polypeptide composing human chimeric antibody
12/17/2002	US6495665 Isoforms of mouse serotonin 5-HT2C receptor
12/17/2002	US6495663 Method and composition for enhancing transport across biological membranes
12/17/2002	US6495662 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
12/17/2002	US6495589 An amino acid derivative useful to increase secretion of growth hormone (gh) from the anterior pituitary of mammals, including on sustained release basis
12/17/2002	US6495570 Combination drug therapy for glycolipid storage diseases
12/17/2002	US6495526 Inhibitors of cell-cycle progression and uses related thereto
12/17/2002	US6495522 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
12/17/2002	US6495521 Combination therapy method for treating chronic hepatitis B
12/17/2002	US6495520 Apoptosis Inducing Molecule II and methods of use
12/17/2002	US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002	US6495518 Method for importing biologically active molecules into cells
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002	US6495515 Inhibiting inflammation mediated by infiltrating macrophages; polypeptide having at least 50% amino acid sequence no:4 homology and biological function of myxoma t7 interferon gamma receptor
12/17/2002	US6495513 Morphogen-enhanced survival and repair of neural cells
12/17/2002	US6495376 Phosphoserine and phosphothreonine binding modules. the ww-domain containing polypeptides of the invention can be used, for example, to regulate cell growth; to treat neurodegenerative diseases; to screen for substances that
12/17/2002	US6495365 Hematopoietic stem cell proliferating agents
12/17/2002	US6495359 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
12/17/2002	US6495349 Chimeric gene constructs
12/17/2002	US6495347 Determining if fusion protein stimulates a th1-like response in cell sample; fusion proteins and conjugates that contain at least a portion of a heat shock protein; response detected by measuring interferon (ifn)-gamma produced by the cell sample
12/17/2002	US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting
12/17/2002	US6495345 Surface antigen
12/17/2002	US6495343 Cloning and recombinant production of CRF receptor(s)
12/17/2002	US6495339 Method of identifying a compound that modulates XAF-mediated apoptosis
12/17/2002	US6495337 Adding a candidate agent to a mixture comprising myosin under conditions which normally allow production of adp or phosphate; change in level between the presence and absence of agent indicates compound as modulator of myosin
12/17/2002	US6495332 Methods and compositions for ameliorating the symptoms of sepsis
12/17/2002	US6495330 Determining the level of p-type inositol phosphoglycans in a biological sample obtained from the patient, wherein said p-type ipgs are capable of activating pyruvate dehydrogenase phosphatase, by immunoassay
12/17/2002	US6495322 Said protein induces apoptosis or is capable of generating or selecting an antibody to claimed amino acid sequence
12/17/2002	US6495321 Randomisation of the entire gene sequence in combination with the selection of a variant (mutant) protein with the desired characteristics, followed by a new round of random mutagenesis and selection
12/17/2002	US6495315 Channel forming toxins as antiviral agents
12/17/2002	US6495144 A peptide having substantial homology with the cbf1/rbpjk (cell binding factor-1/recombination bining protein j kappa) interaction domain of ebna2 comprising specific peptide containing 15-20 amino acids
12/17/2002	US6495139 Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
12/17/2002	US6495138 PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays
12/17/2002	US6495131 Adenovirus vector
12/17/2002	US6495129 Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
12/17/2002	US6495128 Human chemokine β-7 deletion and substitution proteins
12/17/2002	US6495120 Formulation and system for intra-oral delivery of pharmaceutical agents
12/17/2002	CA2260311C Remedy for cag repeat expansion diseases
12/17/2002	CA2250420C Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
12/17/2002	CA2214439C A novel growth factor and a genetic sequence encoding same
12/17/2002	CA2204616C Ppar gamma antagonists for treating obesity
12/17/2002	CA2174031C Benzoyl peroxide compositions
12/17/2002	CA2165520C P substance antagonist used in a pharmaceutical composition
12/17/2002	CA2148652C Substance p antagonist used in a cosmetic composition; composition thus produced
12/17/2002	CA2108977C Luteinizing hormone releasing hormone antagonist peptides
12/17/2002	CA2080260C Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof
12/17/2002	CA2063106C Ciclosporin form for pulmonary administration
12/17/2002	CA2051010C Human luteinizing hormone-chorionic gonadotropin receptor protein, dna and use thereof
12/17/2002	CA1341410C Recombinant acquired immune deficiency syndrome (aids) viral envelope protein and method of testing for aids
12/17/2002	CA1341409C Cloning and expression of htlv-iii dna
12/15/2002	CA2390327A1 Method
12/14/2002	CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators
12/12/2002	WO2002099120A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/12/2002	WO2002099119A2 B7-related nucleic acids and polypeptides useful for immunomodulation
12/12/2002	WO2002099116A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002	WO2002099107A2 Regulation of human trace amine receptor ta5
12/12/2002	WO2002099102A1 Numb protein expression inhibitors by musashi
12/12/2002	WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications

1 ... 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 ... 3163